Navin Fluorine Launches cGMP-4 Plant at Dewas

Navin Fluorine International Limited (NFIL) achieved a milestone with the launch of Phase-1 of its new cGMP-4 plant at the Navin Molecular location within its Dewas unit. The launch, in front of its distinguished European partners, highlights the company's expanding international presence in the specialty chemicals and Contract Development and Manufacturing Organization (CDMO) business.

Vishad P. Mafatlal, NFIL Chairman, and Nitin Kulkarni, Managing Director, were accompanied by the company's leadership for the formal inauguration of the state-of-the-art facility. To international regulatory requirements, the cGMP-4 facility is designed to significantly increase the capabilities of the company's R&D and manufacturing.

"It represents our steadfast focus on innovation, quality, and global collaborations. It allows us to enhance our ability to serve our global customers with world-class infrastructure and delivery capabilities." states Vishad P. Mafatlal.

Also Read: Navin Fluorine introduces Navin Molecular Brand

Nitin Kulkarni noted the strategic significance of the expansion: "The cGMP-4 facility is a cornerstone in our strategy to become a value-trusted, global CDMO partner. It integrates cutting-edge technology with end-to-end value creation."

Navin Fluorine's ongoing commitment to high-quality infrastructure further cements its leadership in the space of specialty chemicals, emphasizing reliability, compliance, and sustainable growth.

The inauguration underscores the proactive nature of the company in addressing global demand and demonstrates its preparedness to offer next-generation chemical solutions to partners across the world